Projects

P1 –

Is the EU-18mg/ml JUUL as Satisfying as the US-59mg/ml JUUL? A Mixed Method Study to Explore the Effects of JUUL and Trajectories of Use

P2 –

Correlates of perceived addiction and product addictiveness of e-cigarettes – the EValuation of the Addictive Potential of E-cigarettes (EVAPE) project

P3 –

Reasons for using e-cigarettes among adult cigarette smokers in France: Findings from the 2019 International Tobacco Control Project France Survey

P4 –

European adult smokers’ perceptions of the harmfulness of e-cigarettes relative to combustible cigarettes: Findings from the France and EUREST-PLUS ITC Surveys

P5 –

Self-reported signs of Substance Use Disorder in e-cigarette online forums

P6 –

Combining app-based behavioral support with electronic nicotine delivery system devices for smoking cessation: a randomized controlled trial

P7 –

An online randomised optimisation experiment to identify effective intervention components to support smokers to use e-cigarettes in a quit attempt

P8 –

Factors associated with smoking cessation in exclusive smokers and dual users of e-cigarette and conventional cigarettes from CDTnet registry.

P9 –

Effect of Tobacco Cessation Aids on Smoking Cessation and Duration of Abstinence: a French Population-Based Study

P10 –

Sensory appeal and puffing intensity of e-cigarette use: influence of nicotine salts versus free-base nicotine in e-liquids

P11 –

Assessment of nicotine protonation state in e-liquids using benchtop NMR spectroscopy

P12 –

E-cigarettes for smoking cessation: the latest Cochrane living systematic review evidence

P13 –

Is there any association between smoker identities and e-cigarette use?

P14 –

Youth’s views and experimentation with disposable e-cigarettes: using focus groups

P15 –

Reducing attractiveness of e-liquids: proposal for a restrictive list of tobacco-related flavorings

P16 –

Vaping among Norwegian smokers and former smokers: Reasons, patterns of use, and smoking cessation activity

P17 –

Hazard analysis of vaping device: consequences of film boiling

P18 –

E-cigarette-use in a global digital youth culture. A qualitative study of the practices and social meaning of vaping among 15–20-year-olds in a Nordic regulatory context

P19 –

Prévalence de l’utilisation de la cigarette électronique chez les migrants consultant dans les PASS de Paris : étude TATAMI (2021)

P20 –

Use of pod device e-cigarettes in the Cessation of Smoking Trial in the Emergency Department

P21 –

The effects of offering a disposable EC versus NRT on smoking cessation outcomes: a retrospective community pharmacy study

P22 –

Prevalence of vaping in France in 2021: results from the Santé publique France Health Barometer

P23 –

E-cigarette Use and its Associated Factors Among a Sample of Romanian Pregnant Smokers and Exsmokers

P24 –

Comparison of chemical composition and toxicity effects of emissions from electronic cigarettes, heated tobacco products and tobacco cigarettes in human bronchial epithelial cells

P25 –

E-cigarette and e-liquids: national reports received by French Poison Control Centers from July 2019 to December 2020

P26 –

REWARD DEFICIENCY SYNDROME : A RATIONAL OF TOBACCO HARM REDUCTION

P27 –

Tobacco and e-cigarette use among French adolescents. Prevalence, trends and associations: where we are in 2022?

P28 –

Switching to e-cigarettes as harm reduction among individuals with pulmonary disease who currently smoke

P29 –

Second-hand smoke exposure in households switching from cigarette to e-cigarette use

P30 –

Using ecological momentary assessment via text messaging to measure cigarette and e-cigarette use patterns

P31 –

The PPI process for selection of an e-cigarette for inclusion in the Cessation of Smoking Trial in the Emergency Department (COSTED)

P32 –

Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review

P33 –

Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations

P34 –

Legislation on the advertising of vaping products in France: a poorly enforced law

P35 –

Tracking via Repeated Assessment of Joint E-Cigarette and Tobacco use (TRAJECT): Descriptive and qualitative findings exploring trajectories of dual e-cigarette and tobacco use

P36 –

Why are electronic cigarettes less addictive than cigarettes? A narrative review of the evidence

P37 –

Effects of electronic cigarettes on smoking cessation in smokers with no plans to quit.

P38 –

An appeal that does not last: French youths’ attitude toward e-cigarette. Results from the ARAMIS study (2014, 2019).

P39 –

“Helping tool or gadget?” Using ENDS while trying to quit smoking: perspectives from the TABATRAJ study

P40 –

JATC2 (second Joint Action on Tobacco Control): strategies and expected outcomes about evaluation of use, abuse potential and health risks for e-cigarettes and other novel tobacco products in the European Union.

P41 –

Determinants of Shisha vaping among high school students in Abidjan-Côte d’Ivoire

P42 –

Adolescents (15-18 years old) in the narratives of experimentation/use trajectories: structuring factors and their effects on transitions between vaping and smoking

P43 –

Facing smoking and/or vaping, abstaining from it, resisting to their re-use and to initiate smoking subsequent to vaping: study of the mechanisms of prevention of the scenario of the first time in adolescents (15-18 years old)

P44 –

Vaping risk perceptions: Systematic review of interventions to change them, and associations with vaping/smoking behaviours

P45 –

Within-person predictors of patterns of dual e-cigarette and tobacco use: the Tracking via Repeated Assessment of Joint E-Cigarette and Tobacco use (TRAJECT) study

P46 –

The impact of electronic cigarette and heated tobacco product on conventional smoking: an Italian prospective cohort study form Italy conducted during the COVID-19 pandemic.

P47 –

The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression

P48 –

Birth-cohort patterns of e-cigarette use among adolescents in the US

P49 –

Electronic Nicotine Delivery Systems (ENDS) use during a five-year period is not associated with selfreported chronic obstructive pulmonary disease (COPD) after adjustment of cigarette smoking history: A longitudinal analysis of PATH data.

P50 –

Unintended consequences of vaping: injuries from poisonings and explosions

P51 –

Process Evaluation for Smoking Cessation Trial in Centres for the Homeless (SCETCH): Preliminary findings

P52 –

Survey of Smoking Behavior, Perception and General knowledge regarding E-cigarette among Medical Students in Thailand.

P53 –

Health effects of vaping – a comprehensive systematic review

P54 –

Do smokers in a snus-prevalent society consider e-cigarettes a relevant replacement for cigarettes if they should stop smoking?

P55 –

Public report and recommendations of the High Council of Public Health (Haut conseil de la santé publique), France on the benefit/risk profile of electronic cigarettes.

P56 –

Methodological critique of laboratory studies on metals in e-cigarettes emissions. Implications for studies on organic toxicants

P57 –

Electronic cigarette packaging in context: an exploratory study